The most transcriptionally active, well-studied, and relevant NF-κB heterodimers in the context of DLBCL are RelA:p50 and cRel:p50, which are regulated by the canonical pathway, and RelB:p52 which is regulated by the non-canonical pathway (40). The gene discussed is NFKB2; the disease is diffuse large B-cell lymphoma.